Verge Medical公司购置了RoVoTM系统,以防止在使用新技术的血管手术中出现风险。 Verge Medical acquires RoVo™ System to prevent risks in vascular procedures with new technology.

Verge Medical公司从2MG医疗公司购买了RoVoTM系统,在其投资组合中增加了一项专利的临时封闭性电离技术(TOE)。 Verge Medical acquired the RoVo™ System from 2MG Medical, adding a patented Temporary Occlusion Embolectomy (TOE) technology to its portfolio. 该系统通过使用真空激活导管捕获和清除碎屑，有助于防止血管手术中的常见风险远端栓塞。 This system helps prevent distal embolization, a common risk during vascular procedures, by using a vacuum-activated catheter to capture and remove debris. 收购支持Verge通过创新的、以医生为重点的解决方案加强血管护理的目标。 The acquisition supports Verge's goal of enhancing vascular care through innovative, physician-focused solutions.